Evidence map›Paper›PMID 18427130›Full record

Trial reportCirculation2008

Depressive symptoms and the risk of atherosclerotic progression among patients with coronary artery bypass grafts.

Gregory A Wellenius, Kenneth J Mukamal, Ambar Kulshreshtha, Sharon Asonganyi, Murray A Mittleman

Open access · bronzeAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Circulation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Anxiety and health-related quality of life after cardiac surgery.Archives of medical sciences. Atherosclerotic diseases · 2020
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. The impact of depression in heart disease.Current psychiatry reports · 2010
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gregory A WelleniusCardiovascular Epidemiology Research Unit, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. gwelleni@bidmc.harvard.edu
Kenneth J Mukamal
Ambar Kulshreshtha
Sharon Asonganyi
Murray A Mittleman
Harvard University · USBoston University · US

Funding

Mechanisms of Air Pollution Health Effects in Subjects with Heart FailureR00ES015774 · NIEHS · BROWN UNIVERSITY · PI WELLENIUS, GREGORY A · 2009 to 2011
$747k
Particulate Air Pollution and Acute Ischemic StrokeF32ES013804 · NIEHS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WELLENIUS, GREGORY A · 2005 to 2006
$100k
NIEHS NIH HHS F32 ES013804NIEHS NIH HHS F32-ES013804NIEHS NIH HHS R00 ES015774
6 · The paper itself

Abstract

backgroundDepressive symptoms have been associated with increased risk of coronary artery disease and poor prognosis among patients with existing coronary artery disease, but whether depressive symptoms specifically influence atherosclerotic progression among such patients is uncertain. METHODS AND

resultsThe Post-CABG Trial randomized patients with a history of coronary bypass graft surgery to either an aggressive or a moderate lipid-lowering strategy and to either warfarin or placebo. Coronary angiography was conducted at enrollment and after a median follow-up of 4.2 years. Depressive symptoms were assessed at enrollment with the Centers for Epidemiologic Studies Depression scale (CES-D) in 1319 patients with 2496 grafts. In models that adjusted for age, gender, race, treatment assignment, and years since coronary bypass graft surgery, a CES-D score > or =16 was positively associated with risk of substantial graft disease progression (OR 1.50, 95% CI 1.08 to 2.10, P=0.02) and marginally associated with a 0.11-mm (95% CI -0.22 to 0.01 mm, P=0.07) decrease in minimum lumen diameter, but not with risk of graft occlusion (P=0.30). Additional adjustment for past medical history, blood pressure, and renal function did not materially alter these results. This association was virtually absent among participants randomly assigned to aggressive lipid-lowering therapy.

conclusionsThese findings suggest that depressive symptoms are associated with a higher risk of atherosclerotic progression among patients with saphenous vein grafts and that aggressive lipid lowering can minimize this increased risk. Whether depressive symptoms increase progression in other types of coronary atherosclerosis and whether aggressive lipid lowering attenuates such progression will require additional study.

Indexed as

AdultAgedAged, 80 and overAtherosclerosisCardiovascular AgentsCoronary Artery BypassCoronary Artery DiseaseDepressionDisease ProgressionFemaleHumansMaleMiddle AgedProspective StudiesRisk FactorsCardiovascular Agents

Identifiers

PMID18427130
PMCPMC2393552
OpenAlexW2034044797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.